Literature DB >> 16555608

Regulating research with human subjects--is the system broken?

Alan R Fleischman1.   

Abstract

There has been a great deal of criticism of the system to regulate research and protect the interests of research participants. Structural problems in the system result from the nature of current research and the regulatory process that was created over thirty years ago. Procedural problems exist because local IRBs show wide variation in practices, resources, quality and experience. Assessment of performance is perhaps the most important problem facing the system since there are no standard measures of outcome or performance for the system as a whole or to assess local IRBs. Is the system broken? No, but it is straining under the weight of a changed research environment and inadequate resources. It has the capacity to respond to the concerns of both the research community and the public by the thoughtful application of present regulations and the creation of performance assessment strategies.

Entities:  

Mesh:

Year:  2005        PMID: 16555608      PMCID: PMC1473133     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  11 in total

1.  Demystifying central review boards: current options and future directions.

Authors:  R J Levine; L Lasagna
Journal:  IRB       Date:  2000 Nov-Dec

2.  Improving protection for research subjects.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2002-05-02       Impact factor: 91.245

3.  The Willowbrook debate: concluded?

Authors:  Louis Goldman
Journal:  World Med       Date:  1973-10-03

4.  Drug trials hide conflicts for doctors.

Authors:  Kurt Eichenwald; Gina Kolata
Journal:  N Y Times Web       Date:  1999-05-16

5.  Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research.

Authors: 
Journal:  Acad Med       Date:  2003-02       Impact factor: 6.893

6.  Why we need legal standards for pediatric research.

Authors:  David Wendler; Heidi Forster
Journal:  J Pediatr       Date:  2004-02       Impact factor: 4.406

7.  Johns Hopkins death brings halt to U.S.-financed human studies.

Authors:  G Kolata
Journal:  N Y Times Web       Date:  2001-07-20

8.  Ethics and clinical research.

Authors:  H K Beecher
Journal:  N Engl J Med       Date:  1966-06-16       Impact factor: 91.245

9.  Racism and research: the case of the Tuskegee Syphilis Study.

Authors:  A M Brandt
Journal:  Hastings Cent Rep       Date:  1978-12       Impact factor: 2.683

10.  Oversight of human participants research: identifying problems to evaluate reform proposals.

Authors:  Ezekiel J Emanuel; Anne Wood; Alan Fleischman; Angela Bowen; Kenneth A Getz; Christine Grady; Carol Levine; Dale E Hammerschmidt; Ruth Faden; Lisa Eckenwiler; Carianne Tucker Muse; Jeremy Sugarman
Journal:  Ann Intern Med       Date:  2004-08-17       Impact factor: 25.391

View more
  4 in total

1.  Local IRBs vs. federal agencies: shifting dynamics, systems, and relationships.

Authors:  Robert L Klitzman
Journal:  J Empir Res Hum Res Ethics       Date:  2012-07       Impact factor: 1.742

2.  From anonymity to "open doors": IRB responses to tensions with researchers.

Authors:  Robert Klitzman
Journal:  BMC Res Notes       Date:  2012-07-03

3.  How local IRBs view central IRBs in the US.

Authors:  Robert Klitzman
Journal:  BMC Med Ethics       Date:  2011-06-23       Impact factor: 2.652

4.  The ethics police?: IRBs' views concerning their power.

Authors:  Robert Klitzman
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.